These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19681336)

  • 41. How vaccines are developed.
    Douglas RG
    Curr Clin Top Infect Dis; 1994; 14():192-204. PubMed ID: 8086115
    [No Abstract]   [Full Text] [Related]  

  • 42. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective.
    Sapirstein W
    Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379
    [No Abstract]   [Full Text] [Related]  

  • 43. The role of costs in comparative effectiveness research.
    Garber AM; Sox HC
    Health Aff (Millwood); 2010 Oct; 29(10):1805-11. PubMed ID: 20921479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individualization at the heart of comparative effectiveness research: the time for i-CER has come.
    Basu A
    Med Decis Making; 2009; 29(6):NP9-NP11. PubMed ID: 19959807
    [No Abstract]   [Full Text] [Related]  

  • 45. [Decision aid: theories-methods in research and clinical development and health strategy].
    Varlan E; Le Paillier R
    Therapie; 1996; 51(2):117-22. PubMed ID: 8763045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Federal official discusses reform. Interview by Debra Mamorsky.
    Vladeck BC
    J Health Care Benefits; 1993; 3(1):37-42. PubMed ID: 10130347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The visible hand. Clinton's health reform could alter prospects for millions of enterprises.
    Collins S
    US News World Rep; 1993 Oct; 115(13):78-9, 82-6. PubMed ID: 10129437
    [No Abstract]   [Full Text] [Related]  

  • 48. Evidence used for approval of new drugs.
    Botstein P
    Isr J Med Sci; 1986; 22(3-4):197-200. PubMed ID: 3528042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introduction. Can comparative effectiveness research help tame rising health care costs?
    Brixner DI
    J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S05. PubMed ID: 22663292
    [No Abstract]   [Full Text] [Related]  

  • 50. Examining costs and benefits in the health care debate.
    Shern D
    Psychiatr Serv; 2009 Apr; 60(4):419. PubMed ID: 19339312
    [No Abstract]   [Full Text] [Related]  

  • 51. Transportability of comparative effectiveness and cost-effectiveness between countries.
    Briggs A
    Value Health; 2010 Jun; 13 Suppl 1():S22-5. PubMed ID: 20618791
    [No Abstract]   [Full Text] [Related]  

  • 52. On reducing waste in foreign clinical trials and postregulation experience.
    Lasagna L
    Clin Pharmacol Ther; 1986 Oct; 40(4):369-72. PubMed ID: 3757400
    [No Abstract]   [Full Text] [Related]  

  • 53. Methods for enhancing the efficiency of dental/oral health clinical trials: current status, future possibilities.
    Barnett ML; Pihlstrom BL
    J Dent Res; 2004 Oct; 83(10):744-50. PubMed ID: 15381712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Principles from clinical trials relevant to clinical practice: Part II.
    Califf RM; DeMets DL
    Circulation; 2002 Aug; 106(9):1172-5. PubMed ID: 12196347
    [No Abstract]   [Full Text] [Related]  

  • 55. Real-World Evidence - What Is It and What Can It Tell Us?
    Sherman RE; Anderson SA; Dal Pan GJ; Gray GW; Gross T; Hunter NL; LaVange L; Marinac-Dabic D; Marks PW; Robb MA; Shuren J; Temple R; Woodcock J; Yue LQ; Califf RM
    N Engl J Med; 2016 Dec; 375(23):2293-2297. PubMed ID: 27959688
    [No Abstract]   [Full Text] [Related]  

  • 56. Economic analysis and clinical trials.
    Drummond MF; Stoddart GL
    Control Clin Trials; 1984 Jun; 5(2):115-28. PubMed ID: 6430644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative PTs, PTTs, cost-effectiveness, and health care reform. Radical changes that make good sense.
    Kitchens CS
    Chest; 1994 Sep; 106(3):661-2. PubMed ID: 8082332
    [No Abstract]   [Full Text] [Related]  

  • 58. Tiny and Forgotten: A Call for Focused Neonatal Policy Reform.
    Bucci-Rechtweg CM; Ward RM
    Ther Innov Regul Sci; 2019 Sep; 53(5):615-617. PubMed ID: 30621453
    [No Abstract]   [Full Text] [Related]  

  • 59. It's time to invite more people to join clinical trials.
    Nature; 2021 Apr; 592(7856):659-660. PubMed ID: 33911278
    [No Abstract]   [Full Text] [Related]  

  • 60. Conference explores impediments to meaningful treatment comparisons. Demand for cost-effectiveness data is impetus.
    Miller JL
    Am J Health Syst Pharm; 1995 Jun; 52(11):1140, 1145-8. PubMed ID: 7656102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.